Thomas J. Long School of Pharmacy Fellowships
Fellowship in Industry Program in Partnership with Genentech

The Thomas J. Long School of Pharmacy is proud to partner with Genentech, Inc. to offer a Fellowship in Industry Program (FIP). Founded in 2017, the program aims to provide exceptional biopharmaceutical industry training for doctor of pharmacy (PharmD) graduates.The goal of the program is to prepare fellows for a career in the pharmaceutical industry by focusing on developing technical, leadership and communication skills. The fellowship will also concentrate on cultivating the fellow's clinical skills while honing their expertise in their area of interest.

Genentech South San Francisco campus
 Genentech South San Francisco campus interior
About Genentech

Genentech was founded in 1976, with a goal to develop a new generation of therapeutics created  from genetically engineered copies of naturally occurring molecules. Today Genentech continues to use genetic engineering along with other advanced techniques to develop medicines that address major unmet medical needs for patients worldwide.

In March 2009, Genentech became a member of the Roche Group. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche  pharmaceutical operations in the United States.

This two-year Clinical Science fellowship provides in-depth exposure to Early Clinical Development and understanding the basic principles of clinical research. The fellow will function as a Clinical Scientist and will support Medical Directors/senior-level Clinical Scientists on a diverse set of clinical development activities.

gRED's OMNI (Ophthalmology, Metabolism, Neurology, Infectious Disease, Immunology) organization is responsible for developing and executing early development clinical strategies in healthy volunteers and patients to provide data for gRED non-oncology new molecular entities with respect to safety, tolerability, efficacy, pharmacokinetics, pharmacodynamics, and the utility of biomarkers.

Activities at Genentech

The fellow will function as a clinical scientist and will support medical directors/senior level clinical scientists on the following activities:

  • Serve as a clinical science representative on cross-functional sub-teams (i.e. protocol execution, clinical, biomarkers, pharmacokinetics)
  • Create, review and present clinical slides for internal (i.e. Genentech/Roche) and external meetings (e.g. Investigator meetings, scientific congresses, advisory boards, site visits, site staff training)
  • Develop understanding of Good Clinical Practice (GCP), International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), FDA, EMA, NICE and other relevant guidelines and regulations
  • Draft abstracts, posters, manuscripts for scientific meetings
  • Author and review of clinical documents (i.e. clinical trial protocols, clarifications and amendments, informed consents, investigator brochures, clinical study reports, investigational new drug submissions)
  • Respond to inquiries from health authorities (e.g. FDA, EMA) and study site ethics committees
  • Partner with the data management team to assist with the development of case report forms
  • Serve as a primary point of contact for study inquiries
  • Contribute to ongoing review of the integrity of clinical trial data
  • Develop understanding of Phase I-II drug development

 

Fellowship Program Dates

The fellowship begins on July 1, 2022 and ends on June 30, 2024.

This two-year Clinical Science fellowship provides in-depth exposure to Early Clinical Development and understanding the basic principles of clinical research. The fellow will function as a Clinical Scientist and will support Medical Directors/senior-level Clinical Scientists on a diverse set of clinical development activities.

Genentech's Oncology Early Clinical Development mission is to provide the clinical leadership and skills to successfully develop novel cancer therapies and the means by which to identify the patients who benefit from them. The organization is responsible for developing strategies for and executing on First-in-Human, Phase 1, and Proof-of-Concept oncology clinical trials. In the role of a Clinical Scientist, the fellow will gain experience in the basic principles of clinical oncology research.

Activities at Genentech

The fellow will function as a clinical scientist and will support medical directors/senior level clinical scientists on the following activities:

  • Serve as a clinical science representative on cross-functional sub-teams (i.e. protocol execution, clinical, biomarkers, pharmacokinetics)
  • Create, review and present clinical slides for internal (i.e. Genentech/Roche) and external meetings (e.g. Investigator meetings, scientific congresses, advisory boards, site visits, site staff training)
  • Develop understanding of Good Clinical Practice (GCP), International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), FDA, EMA, NICE and other relevant guidelines and regulations
  • Draft abstracts, posters, manuscripts for scientific meetings
  • Author and review of clinical documents (i.e. clinical trial protocols, clarifications and amendments, informed consents, investigator brochures, clinical study reports, investigational new drug submissions)
  • Respond to inquiries from health authorities (e.g. FDA, EMA) and study site ethics committees
  • Partner with the data management team to assist with the development of case report forms
  • Serve as a primary point of contact for study inquiries
  • Contribute to ongoing review of the integrity of clinical trial data
  • Develop understanding of Phase I-II drug development

 

Fellowship Program Dates

The fellowship begins on July 1, 2021 and ends on June 30, 2023.

The Genentech Clinical Pharmacology Fellowship program builds on the synergy between the fellow’s comprehensive Doctor of Pharmacy training and Genentech’s innovation in drug development to prepare the individual for a career in the biotechnology/pharmaceutical industry. The fellow will be part of the gRED Clinical Pharmacology Department, which is responsible for applying the principles of quantitative pharmacology to enable selection of a safe and effective dose, route and regimen for small molecules and biologics. The fellow will gain drug development experience at Genentech by completing research projects in clinical pharmacology and/or modeling and simulation and collaborating with scientists across disciplines within Genentech and Roche. These experiences will potentially lead to publications and presentations at scientific conferences and give the fellow exposure to career opportunities in the biotechnology/pharmaceutical industry.

Activities at Genentech

The Fellow will function as a Clinical Pharmacologist and will support research and development projects, which may include the following activities:

  • With guidance from the Genentech and University of the Pacific mentors, design and implement a clinical pharmacology and/or modeling and simulation research project(s).
  • Present the results of the research project(s) at Genentech, University of the Pacific, a local and/or national scientific meeting and/or publish them in a peer-reviewed journal.
  • Serve as a Clinical Pharmacology lead for a healthy volunteer study for a small and/or large molecule project (e.g., food effect, drug-drug interaction, formulation bridging, bioequivalence)
  • Serve as a Clinical Pharmacology lead on cross-functional project sub-teams (including clinicians, pharmacologists, biomarker experts, biostatisticians, regulatory experts), facilitating discussions of clinical pharmacology-related issues
  • Develop clinical pharmacology plans for small and/or large molecule projects and obtain buy-in from the project team with support from their mentor
  • Author clinical pharmacology sections of documents (e.g., clinical trial protocols, investigator brochures, clinical study reports, health authority pre-meeting packages, NDAs, BLAs)
  • Develop hands-on modeling and simulation skills (e.g., noncompartmental, compartmental, PK/PD, and population PK modeling)
  • Develop an understanding of ICH, FDA, EMA, PMDA and other relevant Clinical Pharmacology guidances and apply them in their work
  • Develop an understanding of Phase I-IV drug development in different therapeutic areas

 

Fellowship Program Dates

The fellowship begins on July 1, 2021 and ends on June 30, 2023.

Fellowship Eligibility Requirements

A candidate must be:

  • A permanent resident or citizen of the United States
  • PharmD from an accredited college or university before the start of the fellowship term

Application Process

Candidates must submit the following application materials to pharmfip@pacific.edu

  • Letter of intent
  • Curriculum vitae (CV)
  • Three (3) letters of recommendation emailed directly from letter writer to FIP Director - may be submitted after the application deadline
  • One professional writing sample
  • Unofficial pharmacy school transcript emailed to FIP Director

Application Deadline

  • All applications received by November 6, 2020 will be considered for the fellowship position.
  • All applications received after November 6, 2020 will be reviewed and considered on a rolling basis.
  • Submit to pharmfip@pacific.edu
Spotlight
Jeremy Lim ’12, PharmD

Jeremy Lim ’12, PharmD and Sachin A. Shah, PharmD, FACC, FAHA, professor of pharmacy practice, teamed up to create the Fellowship in Industry Program with the goal of providing exceptional pharmaceutical industry training for PharmD graduates.

Jeremy Lim
Fellowship in Industry Program
Contact Us

Sachin A. Shah, PharmD, FACC, FAHA
Director, Fellowship in Industry Program
Professor of Pharmacy Practice

University of the Pacific
Thomas J. Long School of Pharmacy
3601 Pacific Avenue, Stockton, CA 95211

pharmfip@pacific.edu
707.423.3277